CJC-1295 No DAC
Short-acting modified GHRH analog (mod GRF 1-29) for pulsatile-release research.
CJC-1295 without DAC, also known as modified GRF (1-29), is a short-acting growth-hormone-releasing hormone analog. Its brief half-life makes it a common choice in research designs that aim to mimic natural pulsatile growth-hormone release.
Ingredients
CJC-1295 no DAC (≥98% purity by HPLC). 10 mg lyophilized peptide per vial. No non-active ingredients.
Directions
For research use only. Reconstitute per your study protocol and use within 30 days. Store lyophilized at 2–8°C away from light.
Warnings
NOT FOR HUMAN OR ANIMAL CONSUMPTION. Laboratory research use only. Not approved for human use. Not intended to diagnose, treat, cure, or prevent any disease.
Shipping Information
- • Dispatched within 24 hours on business days
- • Discreet, temperature-aware packaging
- • Tracking provided on every shipment
- • Free shipping on orders over $150
Specifications
Customer Reviews
We have ordered several times and the quality has been consistent every time.
Reliable supplier, strong reconstitution characteristics, no residue.
Great for our continuing research protocols. COA matched expectations.
Arrived fast and well packaged. Lyophilization looked clean with a stable cake.
Excellent purity and consistent third-party results across multiple batches.
Satisfied with the product and documentation provided.
Purity confirmed by independent HPLC. Would order again.
Related Products
Ipamorelin / CJC-1295 Blend
Synergistic growth-hormone secretagogue blend studied for vitality and recovery.
Ipamorelin
Selective pentapeptide growth-hormone secretagogue, supplied on its own.
CJC-1295 with DAC
Long-acting GHRH analog with drug affinity complex for extended half-life studies.
IGF-1 LR3
Long-arginine IGF-1 analog studied for cell growth and differentiation pathways.